SGLT-2 inhibitors show potential in preventing dementia in diabetes patients Sodium glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes may prevent dementia, providing greater benefits with longer treatment,…
Research highlights potential of blood epigenetics for dementia risk assessment New research suggests that epigenetic markers in the blood may be useful for understanding dementia risk. Two linked papers from…
NIH awards $6.9 million to prepare a potential Alzheimer’s treatment for future clinical trials A multidisciplinary team of scientists led by Carlo Ballatore, Ph.D., at the University of California San Diego and Kurt Brunden,…
Omega-3 fatty acids show potential in protecting brain health in older adults A recent one JAMA network opened study assesses the role of ω-3 polyunsaturated fatty acids (PUFAs) in reducing white matter…
